# Cemented dual mobility cup for primary total hip arthroplasty: survival and quality of life. A multicenter study

**Authors:** Jairo Alonso Rincón, Camilo de la Pava, Rubén Velandia, Sofía Muñoz-Medina, Andre Ferreira

PMC · DOI: 10.1051/sicotj/2025006 · SICOT-J · 2025-03-13

## TL;DR

A study found that cemented dual mobility cups used in hip replacements have good survival rates and quality of life outcomes over up to 9.5 years.

## Contribution

This study evaluates the long-term survival and quality of life outcomes of cemented dual mobility cups in primary total hip arthroplasty.

## Key findings

- The 5-year survival rate of cemented dual mobility cups was 94.2%.
- Three implant failures occurred, including two dislocations and one mechanical loosening.
- Patients achieved an average Oxford Hip Scale score of 41.5 points.

## Abstract

Introduction: Dual mobility cups are characterized by having a prosthetic head inside a polyethylene core that later articulates with a metal cup implanted in the acetabulum. These cups can be cemented or uncemented. This study aimed to determine the survival of a cemented dual-mobility cup (CDMC) with a cobalt-chromium head (CoCr) and the quality of life (QOL) of operated patients. Methodology: Multicenter historical cohort study where survival and QOL were estimated. The cohort includes patients who underwent a primary total hip arthroplasty (THA) with a CDMC and CoCr head. The patients were operated on between 2011 and 2013. Results: 40 patients from 6 institutions with a median age of 81 (IQR 22.25) years. The results in the Kaplan-Meier estimation showed a survival of 94.2% (95% CI [86.6% – 100%]) at 5 years and a maximum follow-up of 9.5 years. Three failures occurred (two dislocations and one mechanical loosening), and Oxford Hip Scale (OHS) of 41.5 (IQR 10.50) points was recorded. Conclusions: In terms of survival and the score obtained in the OHS, the CDMC has comparable results with the scientific literature found on uncemented dual mobility cups. This demonstrates adequate results in patients with a maximum follow-up of 9.5 years.

## Full-text entities

- **Diseases:** hip arthroplasty (MESH:D025981), dislocations (MESH:D004204)
- **Chemicals:** cobalt-chromium (-), polyethylene (MESH:D020959)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11905767/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11905767/full.md

## References

28 references — full list in the complete paper: https://tomesphere.com/paper/PMC11905767/full.md

---
Source: https://tomesphere.com/paper/PMC11905767